Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin

Cancer Prevention Research

Volumn 6, Issue 12, 2013, Pages 1356-1364

  Lee, Sung Young ^a,b   Lim, Tae Gyu ^a,f   Chen, Hanyong ^a   Jung, Sung Keun ^a   Lee, Hyo Jeong ^e   Lee, Mee Hyun ^a   Kim, Dong Joon ^a,g   Shin, Aram ^b   Lee, Ki Won ^c,d,f   Bode, Ann M ^a   Surh, Young Joon ^b   Dong, Zigang ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Department of Molecular Medicine and Biopharmaceutical Sciences   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

^e Kyung Hee University   (South Korea)

^f Seoul National University   (South Korea)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; ESCULETIN; KI 67 ANTIGEN; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; WNT PROTEIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; COLON CANCER; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; EMBRYO, NONMAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICE; MICE, NUDE; MODELS, MOLECULAR; PROTEIN CONFORMATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UMBELLIFERONES; XENOGRAFT MODEL ANTITUMOR ASSAYS; XENOPUS LAEVIS;

EID: 84890470036     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0241     Document Type: Article

References (48)

1. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 2004;5:691-701.
2. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
3. Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 1999;18:7860-72.
4. Moon RT. Teaching resource. Canonical Wnt/beta-catenin signaling. Sci STKE 2004;2004:tr5.
5. Peifer M, Polakis P. Wnt signaling in oncogenesis andembryogenesis- a look outside the nucleus. Science 2000;287:1606-9.
6. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
7. Sokol SY. Wnt signaling and dorso-ventral axis specification in vertebrates. Curr Opin Genet Dev 1999;9:405-10.
8. De Robertis EM, Kuroda H. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Bio1 2004;20:285-308.
9. Wang J, Sinha T, Wynshaw-Boris A. Wnt signaling in mammalian development: lessons from mouse genetics. Cold Spring Harb Perspect Biol 2012;4:pii:a007963.
10. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Bio1 1998;14:59-88.
11. Flaherty MP, Kamerzell TJ, Dawn B. Wnt signaling and cardiac differentiation. Prog Mol Biol Transl Sci 2012;111:153-74.
12. Kharaishvili G, Simkova D, Makharoblidze E, Trtkova K, Kolar Z, Bouchal J. Wnt signaling in prostate development and carcinogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011;155:11-8.
13. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, et al. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002;21:5548-56.
14. Miyoshi K, Hennighausen L. Beta-catenin: a transforming actor on many stages. Breast Cancer Res 2003;5:63-8.
15. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006;25:7531-7.
16. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787-90.
17. Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 2002;64:27-43.
18. Moravec M. [Colorectal cancer and canonical Wnt signaling pathway]. Cas Lek Cesk 2012;151:335-42.
19. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol Biol 2007;361:63-91.
20. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004;4:653-71.
21. Kikuchi A. Roles of Axin in the Wnt signaling pathway. Cell Signal 1999;11:777-88.
22. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012;149:1192-205.
23. Behrens J. The role of the Wnt signaling pathway in colorectal tumorigenesis. Biochem Soc Trans 2005;33:672-5.
24. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
25. Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS, et al. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 2010;6:e1000816.
26. Klaus A, Birchmeier W. Wnt signaling and its impact on development and cancer. Nat Rev Cancer 2008;8:387-98.
27. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
28. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96:5522-7.
29. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
30. Cai Y, Luo Q, Sun M, Corke H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 2004;74:2157-84.
31. Bubols GB, Vianna DD, Medina-Remon A, von Poser G, Lamuela- Raventos RM, Eifler-Lima VL, et al. The antioxidant activity of coumarins and flavonoids. Mini Rev Med Chem 2012;13:318-34.
32. Ng TB, Liu F, Wang ZT. Antioxidative activity of natural products from plants. Life Sci 2000;66:709-23.
33. Adfa M, Yoshimura T, Komura K, Koketsu M. Antitermite activities of coumarin derivatives and scopoletin from Protium javanicum Burm. f. J Chem Ecol 2010;36:720-6.
34. Panossian AG. Inhibition of arachidonic acid 5-lipoxygenase of human polymorphonuclear leukocytes by esculetin. Biomed Biochim Acta 1984;43:1351-5.
35. Sekiya K, Okuda H, Arichi S. Selective inhibition of platelet lipoxygenase by esculetin. Biochim Biophys Acta 1982;713:68-72.
36. Awaad AS, Al-Jaber NA, Soliman GA, Al-Outhman MR, Zain ME, Moses JE, et al. New biological activities of Casimiroa edulis leaf extract and isolated compounds. Phytother Res 2012;26:452-7.
37. Kaneko T, Tahara S, Takabayashi F. Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons. Biol Pharm Bull 2007;30:2052-7.
38. Yang J, Xiao YL, He XR, Qiu GF, Hu XM. Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells. J Asian Nat prod Res 2010;12:185-93.
39. Matsunaga K, Yoshimi N, Yamada Y, Shimizu M, Kawabata K, Ozawa Y, et al. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitro-sourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res 1998;89:496-501.
40. Schrödinger Suite Schrödinger, LLC; 2011.
41. Miller JR, Mikol Y. Surveillance for diarrheal disease in New York City. J Urban Health 1999;76:388-90.
42. Graham TA, Weaver C,MaoF, Kimelman D, Xu W. Crystal structure of a beta-catenin/Tcf complex. Cell 2000;103:885-96.
43. Poy F, Lepourcelet M, Shivdasani RA, Eck MJ. Structure of a human Tcf4-beta-catenin complex. Nat Struct Biol 2001;8:1053-7.
44. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28:235- 42.
45. Zhou JJ, Xie GR, Yan XJ. Traditional Chinese medicines: Molecular structures, natural sources and applications. China: Chemical Industry Press; 2004.
46. Moon RT, Kimelman D. From cortical rotation to organizer gene expression: toward a molecular explanation of axis specification in Xenopus. BioEssays 1998;20:536-45.
47. Sommer T, Hirsch C. San1p, checking up on nuclear proteins. Cell 2005;120:734- 6.
48. Liu J, Xing Y, Hinds TR, Zheng J, Xu W. The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. J Mol Biol 2006;360:133-44.